W.W.SchmutzlerW.W., B.B.NeukirchB.B., R.R.ZiescheR.R., Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine), „International Archives of Allergy and Applied Immunology”, 88 (1-2), 1989, s. 244–246, DOI: 10.1159/000234798, PMID: 2468618.
GyörgyG.HaskóGyörgyG., Michail V.M.V.SitkovskyMichail V.M.V., CsabaC.SzabóCsabaC., Immunomodulatory and neuroprotective effects of inosine, „Trends in Pharmacological Sciences”, 25 (3), 2004, s. 152–157, DOI: 10.1016/j.tips.2004.01.006, PMID: 15019271.
MihaelaM.PetrovaMihaelaM. i inni, Isoprinosine affects serum cytokine levels in healthy adults, „Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research”, 30 (4), 2010, s. 223–228, DOI: 10.1089/jir.2009.0057, PMID: 20038210.
A.A.MartonA.A. i inni, Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro, „International Journal of Molecular Medicine”, 8 (6), 2001, s. 617–621, DOI: 10.3892/ijmm.8.6.617, PMID: 11712075.
JunkoJ.MutoJunkoJ. i inni, Oral administration of inosine produces antidepressant-like effects in mice, „Scientific Reports”, 4, 2014, art. nr 4199, DOI: 10.1038/srep04199, ISSN2045-2322, PMID: 24569499, PMCID: PMC3935199 [dostęp 2018-11-30].
A.J.A.J.WagstaffA.J.A.J., D.D.FauldsD.D., K.L.K.L.GoaK.L.K.L., Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy, „Drugs”, 47 (1), 1994, s. 153–205, DOI: 10.2165/00003495-199447010-00009, PMID: 7510619.
Generoso G.G.G.GasconGeneroso G.G.G., Randomized Treatment Study of Inosiplex Versus Combined Inosiplex and Intraventricular Interferon-α in Subacute Sclerosing Panencephalitis (SSPE): International Multicenter Study, „Journal of Child Neurology”, 18 (12), 2003, s. 819–827, DOI: 10.1177/088307380301801201, PMID: 14736075.
ErdalE.ErogluErdalE. i inni, Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis, „Journal of the Neurological Sciences”, 275 (1-2), 2008, s. 113–116, DOI: 10.1016/j.jns.2008.07.033, PMID: 18783800.
SofiaS.GeorgalaSofiaS. i inni, Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study, „Acta Dermato-Venereologica”, 86 (5), 2006, s. 422–424, DOI: 10.2340/00015555-0138, PMID: 16955187.
J.A.J.A.KovacsJ.A.J.A. i inni, Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection, „Antimicrobial Agents and Chemotherapy”, 37 (6), 1993, s. 1227–1231, DOI: 10.1128/AAC.37.6.1227, PMID: 7687120, PMCID: PMC187944.
W.W.SchmutzlerW.W., B.B.NeukirchB.B., R.R.ZiescheR.R., Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine), „International Archives of Allergy and Applied Immunology”, 88 (1-2), 1989, s. 244–246, DOI: 10.1159/000234798, PMID: 2468618.
GyörgyG.HaskóGyörgyG., Michail V.M.V.SitkovskyMichail V.M.V., CsabaC.SzabóCsabaC., Immunomodulatory and neuroprotective effects of inosine, „Trends in Pharmacological Sciences”, 25 (3), 2004, s. 152–157, DOI: 10.1016/j.tips.2004.01.006, PMID: 15019271.
MihaelaM.PetrovaMihaelaM. i inni, Isoprinosine affects serum cytokine levels in healthy adults, „Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research”, 30 (4), 2010, s. 223–228, DOI: 10.1089/jir.2009.0057, PMID: 20038210.
A.A.MartonA.A. i inni, Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro, „International Journal of Molecular Medicine”, 8 (6), 2001, s. 617–621, DOI: 10.3892/ijmm.8.6.617, PMID: 11712075.
JunkoJ.MutoJunkoJ. i inni, Oral administration of inosine produces antidepressant-like effects in mice, „Scientific Reports”, 4, 2014, art. nr 4199, DOI: 10.1038/srep04199, ISSN2045-2322, PMID: 24569499, PMCID: PMC3935199 [dostęp 2018-11-30].
G.R.G.R.KinghornG.R.G.R. i inni, Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection, „Genitourinary Medicine”, 68 (5), 1992, s. 312–316, PMID: 1385295, PMCID: PMC1195986.
A.J.A.J.WagstaffA.J.A.J., D.D.FauldsD.D., K.L.K.L.GoaK.L.K.L., Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy, „Drugs”, 47 (1), 1994, s. 153–205, DOI: 10.2165/00003495-199447010-00009, PMID: 7510619.
Generoso G.G.G.GasconGeneroso G.G.G., Randomized Treatment Study of Inosiplex Versus Combined Inosiplex and Intraventricular Interferon-α in Subacute Sclerosing Panencephalitis (SSPE): International Multicenter Study, „Journal of Child Neurology”, 18 (12), 2003, s. 819–827, DOI: 10.1177/088307380301801201, PMID: 14736075.
ErdalE.ErogluErdalE. i inni, Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis, „Journal of the Neurological Sciences”, 275 (1-2), 2008, s. 113–116, DOI: 10.1016/j.jns.2008.07.033, PMID: 18783800.
SofiaS.GeorgalaSofiaS. i inni, Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study, „Acta Dermato-Venereologica”, 86 (5), 2006, s. 422–424, DOI: 10.2340/00015555-0138, PMID: 16955187.
J.A.J.A.KovacsJ.A.J.A. i inni, Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection, „Antimicrobial Agents and Chemotherapy”, 37 (6), 1993, s. 1227–1231, DOI: 10.1128/AAC.37.6.1227, PMID: 7687120, PMCID: PMC187944.
